These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 29675020)

  • 21. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epicardial Adipose Tissue Inflammation Can Cause the Distinctive Pattern of Cardiovascular Disorders Seen in Psoriasis.
    Packer M
    Am J Med; 2020 Mar; 133(3):267-272. PubMed ID: 31520623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis--a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives.
    Boehncke WH; Sterry W
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):946-52. PubMed ID: 19341429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psoriasis as metabolic and cardiovascular risk factor].
    Tupikowska M; Zdrojowy-Welna A; Maj J
    Pol Merkur Lekarski; 2014 Aug; 37(218):124-7. PubMed ID: 25252450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is psoriasis a dependent cardiovascular risk factor?].
    Wakkee M; de Jong EM
    Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metabolic syndrome in patients with psoriasis].
    Wolska K; Michalska-Jakubus M; Pietrzak A; Krasowska D
    Pol Merkur Lekarski; 2014 Mar; 36(213):215-9. PubMed ID: 24779224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis.
    Pirro M; Stingeni L; Vaudo G; Mannarino MR; Ministrini S; Vonella M; Hansel K; Bagaglia F; Alaeddin A; Lisi P; Mannarino E
    Eur J Prev Cardiol; 2015 Aug; 22(8):1027-35. PubMed ID: 24906366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical cardiovascular disease in plaque psoriasis: association or causal link?
    Shaharyar S; Warraich H; McEvoy JW; Oni E; Ali SS; Karim A; Jamal O; Blaha MJ; Blumenthal RS; Fialkow J; Cury R; Budoff MJ; Agatston AA; Nasir K
    Atherosclerosis; 2014 Jan; 232(1):72-8. PubMed ID: 24401219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiovascular risk profile of patients with psoriasis].
    Di Lisi D; Macaione F; Corrado E; Bonura F; Novo G; Peritore A; Meschisi M; Cuttitta F; Bongiorno MR; Novo S
    Recenti Prog Med; 2013 Mar; 104(3):102-5. PubMed ID: 23548953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time.
    Merzel Šabović EK; Starbek Zorko M; Janić M
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?
    Orlando G; Molon B; Viola A; Alaibac M; Angioni R; Piaserico S
    Front Immunol; 2022; 13():868277. PubMed ID: 35686132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comorbidity in psoriasis].
    Gerdes S; Mrowietz U; Boehncke WH
    Hautarzt; 2016 Jun; 67(6):438-44. PubMed ID: 27221798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.
    Bonanad C; González-Parra E; Rivera R; Carrascosa JM; Daudén E; Olveira A; Botella-Estrada R
    Actas Dermosifiliogr; 2017 Nov; 108(9):800-808. PubMed ID: 28610662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis: comorbidities and associations.
    Farley E; Menter A
    G Ital Dermatol Venereol; 2011 Feb; 146(1):9-15. PubMed ID: 21317853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
    Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
    Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.